Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy
Kai Tang, Bo Wang, Bin Yu, Hong‐Min Liu
Topics & Concepts
KynurenineChemistryIndoleamine 2,3-dioxygenaseCancer therapyKynurenine pathwayCancerLimitingEnzymePharmacologyCancer researchTryptophanBiochemistryMedicineInternal medicineAmino acidMechanical engineeringEngineeringTryptophan and brain disordersHistone Deacetylase Inhibitors ResearchPharmacological Receptor Mechanisms and Effects